Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | F10 | P00742 | 2/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13870199 | 0.80 | KMT2A (0.39) | KMT2ATSHRALDH1A1ESR1HSD17B10 | |
| SCHEMBL24833770 | 0.78 | KMT2A (0.42) | KMT2ATSHRALDH1A1ESR1HSD17B10 | |
| SCHEMBL1139067 | 0.77 | TSHR (0.50) | KMT2ATSHRALDH1A1ESR1HSD17B10 | |
| SCHEMBL7933474 | 0.76 | — | — | |
| SCHEMBL13887223 | 0.76 | KMT2A (0.43) | KMT2ATSHRALDH1A1ESR1HSD17B10 | |
| SCHEMBL13760464 | 0.75 | TSHR (0.45) | KMT2ATSHRALDH1A1ESR1HSD17B10 | |
| SCHEMBL241284 | 0.75 | KMT2A (0.50) | KMT2ATSHRALDH1A1ESR1HSD17B10 | |
| SCHEMBL14523163 | 0.73 | KMT2A (0.39) | KMT2ATSHRALDH1A1ESR1HSD17B10 | |
| Acetic Acid SCHEMBL13732260 | 0.72 | KMT2A (0.51) | KMT2ATSHRALDH1A1ESR1HSD17B10 | |
| SCHEMBL8811351 | 0.70 | KMT2A (0.47) | KMT2ATSHRALDH1A1ESR1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9358195-B2 | Stabilized body care products, household products, textiles and fabrics | BASF SE (DE) | 2016-06-07 | — | — | US | disclosed |
| US-20050220727-A1 | Stabilized body care products, household products, textiles and fabrics | CIBA CORPORATION | 2005-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050220727-A1 | Stabilized body care products, household products, textiles and fabrics | CUTA, DHRS9, DSC1 | KMT2A 789/4885TSHR 1597/4885ALDH1A1 816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.